Monday, 16 Sep 2019


Datesort ascending Type Title Save
14 Sep 2018 News Biologic Therapies Improve Work Outcomes in Spondyloarthritis
13 Sep 2018 Social Norwegian study of 108 pregnancies in 103 Psoriatic arthritis women finds that 75% were in DAS remission or LDAS during and after pregnancy; For most Dz activity decreased during pregnancy but increased postpartum especialyly after 6 mos postpartum
12 Sep 2018 News BMS Tyk 2 Inhibitor Benefits Psoriasis
09 Sep 2018 Social Excellent open review of obesity's influence on disease onset (RA, PsA), pathogenesis, disease progression, functional consequences and treatment interference.
06 Sep 2018 News Methotrexate's Low Efficacy in Cutaneous Psoriasis
31 Aug 2018 Social RheumNow Week in Review is up – Father Knows Best and more info on Contraceptive let downs, good outcomes in PsA, depression-insomnia-pain triad in OA and how to store your biologic in a hurricaine.
30 Aug 2018 News No Cancer Risk from Psoriatic Arthritis
30 Aug 2018 Social RT @RheumJnl: The BSRBR has published outcomes on their PsA cohort. Incidence of overall malignancy similar to general population, although…
24 Aug 2018 News Treatments Do Not Increase Infection Risk in Ankylosing Spondylitis
21 Aug 2018 News Dietary Recommendations for Psoriatic Disease
13 Aug 2018 Social Data from a prospective longitudinal cohort of PsA patients shows that greater Xray damage is associated with exposure to prolonged repetitive hand movements and occupations with higher level of finger dexterity
13 Aug 2018 Social Unmet need in Psoriatic Arthritis! 10 Yr study of 331 PsA pts from Norway shows no increase in remission rates, no signif change in PRO's and no increase in DMARD or biologic use. Large need for T2T remission in PsA.
06 Aug 2018 News Back Pain in Psoriatic Arthritis
02 Aug 2018 Social Metanalysis of 266 studies examining 976,408 psoriasis patients shows the prevalence of PsA among patients with psoriasis was 19.7% (18.5%-20.9%). In children and adolescents (<18 years), the pooled prevalence was 3.3%
26 Jul 2018 News Minimal Disease Activity: The Goal in PsA
15 Jul 2018 Social European Commission has approved combination Xeljanz 5 mg BID in combination with MTX for the treatment of active psoriatic arthritis with an inadequate response/intolerance to DMARDs
11 Jul 2018 News Liver Disease Increased in Psoriasis
06 Jul 2018 News Best of 2017: Cause of Death in Ankylosing Spondylitis
29 Jun 2018 News Ixekizumab Effective in Ankylosing Spondylitis
29 Jun 2018 Social European Commission has approved XELJANZ® (tofacitinib citrate) 5 mg twice daily (BID) in combination with methotrexate (MTX) for the treatment of adults with active psoriatic arthritis (PsA) with an inadequate response to DMARDs